GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $3,392,000 | +25.3% | 84,061 | +19.4% | 3.84% | +22.0% |
Q3 2015 | $2,707,000 | -26.0% | 70,401 | -19.8% | 3.14% | -3.4% |
Q2 2015 | $3,656,000 | -9.1% | 87,781 | +0.7% | 3.26% | -2.5% |
Q1 2015 | $4,022,000 | -36.9% | 87,146 | -45.1% | 3.34% | -34.3% |
Q4 2014 | $6,372,000 | +97.9% | 158,795 | +126.8% | 5.08% | +146.8% |
Q3 2014 | $3,219,000 | -6.5% | 70,015 | +8.7% | 2.06% | +15.2% |
Q2 2014 | $3,444,000 | – | 64,400 | – | 1.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |